Stocks Clearmind Begins Phase I/IIa Study to Treat Alcohol Use Disorder From Investing.comFebruary 23, 2024 VANCOUVER, Canada – Clearmind Medicine Inc. (NASDAQ:CMND), (CSE:CMND), (FSE:CWY), a biotechnology company specializing in psychedelic…
